Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison.

MLA

Curtis, Michael, et al. “Switching of Opioid Agonist Treatment Modality during Imprisonment: A Novel Marker for Increased Support Need during and Following Release from Prison.” The International Journal on Drug Policy, vol. 100, Feb. 2022, p. 103572. EBSCOhost, https://doi.org/10.1016/j.drugpo.2021.103572.

APA

Curtis, M., Berk, J., Larney, S., Rich, J. D., & Stoové, M. (2022). Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison. The International Journal on Drug Policy, 100, 103572. https://doi.org/10.1016/j.drugpo.2021.103572

Chicago

Curtis, Michael, Justin Berk, Sarah Larney, Josiah D Rich, and Mark Stoové. 2022. “Switching of Opioid Agonist Treatment Modality during Imprisonment: A Novel Marker for Increased Support Need during and Following Release from Prison.” The International Journal on Drug Policy 100 (February): 103572. doi:10.1016/j.drugpo.2021.103572.